Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

RadiothErapy priMIng for CAR-T

NCT04726787

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • St James's University Hospital Leeds, United Kingdom
  • Kings College Hospital London, United Kingdom
  • Freeman Hospital Newcastle, United Kingdom
View Trial Details
Active, Not Recruiting

Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma

NCT02315716

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Queen's Hospital Romford, Essex, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • NHS Lanarkshire Bothwell, United Kingdom
View all 20 locations
View Trial Details
Active, Not Recruiting

Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)

NCT02406222

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Belfast Health & Social Care Trust Belfast, United Kingdom
  • University of Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • Royal Sussex County Hospital Brighton, United Kingdom
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma

NCT03671018

Conditions
B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

NCT03989414

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 119 Denver, Colorado, United States
  • Local Institution - 104 Tampa, Florida, United States
  • Local Institution - 108 Atlanta, Georgia, United States
  • Local Institution - 112 Chicago, Illinois, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT03155191

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Akita University Hospital Akita, Japan
  • University Of Fukui Hospital Yoshida, Fukui, Japan
  • Kyushu University Hospital Higashiku, Fukuoka, Japan
  • Hokkaido University Hospital Sapporo, Hokkaido, Japan
View Trial Details
Active, Not Recruiting

MInimal Residual Disease Adapted Strategy

NCT04934475

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Grand Hôpital de Charleroi - Site de Notre-Dame Charleroi, Belgium
  • Hôpital Jolimont Haine-Saint-Paul, Belgium
View all 73 locations
View Trial Details

Related conditions